FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

377435002: Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1202754013 Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution (product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    1475924012 Gramicidin+neomycin sulfate+polymyxin b sulphate 0.025mg/1.75mg/10000unt solution en Synonym Active Entire term case insensitive SNOMED CT core module
    1476885016 Gramicidin+neomycin sulfate+polymyxin b sulfate 0.025mg/1.75mg/10000unt solution en Synonym Active Entire term case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Is a Product containing gramicidin false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Is a Product containing neomycin false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Is a Polymyxin B eye drops false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Is a Compound neomycin preparations false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Is a Product containing neomycin in topical dosage form false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has active ingredient Polymyxin B false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has active ingredient Topical neomycin false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has active ingredient Gramicidin false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Is a Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has active ingredient Polymyxin B sulfate false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has active ingredient Skin anti-infective false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has active ingredient Neomycin sulfate false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has active ingredient Local anti-infective false Inferred relationship Existential restriction modifier
    Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has manufactured dose form Ocular dose form false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start